{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:30:55Z","timestamp":1784179855590,"version":"3.55.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,3,25]],"date-time":"2002-03-25T00:00:00Z","timestamp":1017014400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/1471-2458-2-6","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:40:44Z","timestamp":1034361644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?"],"prefix":"10.1186","volume":"2","author":[{"given":"Ashley M","family":"Croft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Herxheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,3,25]]},"reference":[{"key":"23_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.7326\/0003-4819-70-1-150","volume":"70","author":"WD Tigertt","year":"1969","unstructured":"Tigertt WD: The army malaria research program. Ann Intern Med. 1969, 70: 150-3.","journal-title":"Ann Intern Med"},{"key":"23_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00023210-199911010-00001","volume":"11","author":"F Nosten","year":"1999","unstructured":"Nosten F, van Vugt M: Neuropsychiatric adverse effects of mefloquine \u2013 what do we know and what should we do?. CNS Drugs. 1999, 11: 1-8.","journal-title":"CNS Drugs"},{"key":"23_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1046\/j.1365-3156.1998.00163.x","volume":"3","author":"AM R\u00f8nn","year":"1998","unstructured":"R\u00f8nn AM, R\u00f8nne-Rasmussen J, G\u00f8tzsche P, Bygbjerg IC: Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study. Trop Med Int Health. 1998, 3: 83-8. 10.1046\/j.1365-3156.1998.00163.x.","journal-title":"Trop Med Int Health"},{"key":"23_CR4","volume-title":"Geneva: WHO","author":"World Health Organisation","year":"1991","unstructured":"World Health Organisation: Review of central nervous system adverse events to the antimalarial drug mefloquine (1985\u20131990). Geneva: WHO. 1991, . Report no: WHO\/mal 91.1063."},{"key":"23_CR5","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1086\/322694","volume":"33","author":"D Overbosch","year":"2001","unstructured":"Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, et al: Atovaquone-proguanil versus mefloquine for malaria prophylaxis in non-immune travelers: results from a randomized double-blind study. Clin Infect Dis. 2001, 33: 1015-21. 10.1086\/322694.","journal-title":"Clin Infect Dis"},{"key":"23_CR6","first-page":"167","volume":"95","author":"L Bem","year":"1992","unstructured":"Bem L, Kerr L, Stuerchler D: Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions. J Trop Med Hyg. 1992, 95: 167-9.","journal-title":"J Trop Med Hyg"},{"key":"23_CR7","volume-title":"International Travel and Health","author":"World Health Organisation","year":"2001","unstructured":"World Health Organisation: International Travel and Health. 2001"},{"key":"23_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1708-8305.1999.tb00843.x","volume":"6","author":"P Schlagenhauf","year":"1999","unstructured":"Schlagenhauf P: Mefloquine for malaria chemoprophylaxis 1992\u20131998: a review. J Travel Med. 1999, 6: 122-33.","journal-title":"J Travel Med"},{"key":"23_CR9","unstructured":"Toegenomen transpiratie met mefloquine (Lariam\u00ae). Geneesmiddelen Bulletin. 1997, 31: 97-"},{"key":"23_CR10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4269\/ajtmh.1991.45.86","volume":"45","author":"T Weinke","year":"1991","unstructured":"Weinke T, Trautmann M, Held T, Weber G, Eichenlaub D, Fleischer K, Kern W, Pohle HD: Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg. 1991, 45: 86-91.","journal-title":"Am J Trop Med Hyg"},{"key":"23_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/bmj.313.7056.525","volume":"313","author":"PJ Barrett","year":"1996","unstructured":"Barrett PJ, Emmins PD, Clarke PD, Bradley DJ: Comparison of adverse events associated with use of mefloquine and combinations of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ. 1996, 313: 525-8.","journal-title":"BMJ"},{"key":"23_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1708-8305.1996.tb00729.x","volume":"3","author":"D Huzly","year":"1996","unstructured":"Huzly D, Sch\u00f6nfeld C, Beurle W, Bienzle U: Malaria chemoprophylaxis in German tourists: a prospective study on compliance and adverse reactions. J Travel Med. 1996, 3: 148-55.","journal-title":"J Travel Med"},{"key":"23_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1708-8305.1996.tb00695.x","volume":"3","author":"MA Phillips","year":"1996","unstructured":"Phillips MA, Kass RB: User acceptability patterns for mefloquine and doxycycline malaria chemoprophylaxis. J Travel Med. 1996, 3: 40-5.","journal-title":"J Travel Med"},{"key":"23_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1365-3156.1996.d01-85.x","volume":"1","author":"P Schlagenhauf","year":"1996","unstructured":"Schlagenhauf P, Steffen R, Lobel H, Johnson R, Letz R, Tschopp A, Vranjes N, Bergqvist Y, Ericsson O, Hellgren U, et al: Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Trop Med Int Health. 1996, 1: 485-94. 10.1046\/j.1365-3156.1996.d01-85.x.","journal-title":"Trop Med Int Health"},{"key":"23_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1708-8305.1997.tb00798.x","volume":"4","author":"JC Handschin","year":"1997","unstructured":"Handschin JC, Wall M, Steffen R, St\u00fcrchler D: Tolerability and effectiveness of malaria chemoprophylaxis with mefloquine or chloroquine with or without co-medication. J Travel Med. 1997, 4: 121-7.","journal-title":"J Travel Med"},{"key":"23_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002280050240","volume":"52","author":"MM van Riemsdijk","year":"1997","unstructured":"van Riemsdijk MM, van der Klauw MM, van Heest JAC, Reedeker FR, Ligthelm RJ, Herings RMC, Stricker BHC, et al: Neuro-psychiatric effects of antimalarials. Eur J Clin Pharmacol. 1997, 52: 1-6. 10.1007\/s002280050240.","journal-title":"Eur J Clin Pharmacol"},{"key":"23_CR17","volume-title":"Proceedings of the Second European Conference on Travel Medicine; 2000 Mar 29\u201331; Venice, Italy. Venice: Fondazione Cini","author":"C Micheo","year":"2000","unstructured":"Micheo C, Arias C, Rovira A: Adverse effects and compliance with mefloquine or chloroquine + proguanil malaria chemoprophylaxis. Proceedings of the Second European Conference on Travel Medicine; 2000 Mar 29\u201331; Venice, Italy. Venice: Fondazione Cini. 2000"},{"key":"23_CR18","first-page":"441","volume":"112","author":"H Kollaritsch","year":"2000","unstructured":"Kollaritsch H, Karbwang J, Wiedermann G, et al: Mefloquin-Konzentrationsprofile bei prophylaktischer Dosierung. Wien Klin Wochenschr. 2000, 112: 441-7.","journal-title":"Wien Klin Wochenschr"},{"key":"23_CR19","first-page":"331","volume":"41","author":"BA Wolters","year":"1996","unstructured":"Wolters BA, Bosje T, Luinstra-Passchier MJ: Niet meer klachten bij mefloquinegebruik dan bij malariaprofylaxe met andere middelen. Ned Tijdschr Geneeskd. 1996, 41: 331-4.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"23_CR20","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1128\/AAC.37.9.1977","volume":"37","author":"FM Smithuis","year":"1993","unstructured":"Smithuis FM, van Woensel JBM, Nordlander E, Vantha WS, ter Kuile FO: Comparison of two mefloquine regimens for treatment of lasmodium falciparum malaria on the northeastern Thai-Cambodian border. Antimicrob Agents Chemother. 1993, 37: 1977-81.","journal-title":"Antimicrob Agents Chemother"},{"key":"23_CR21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/02724936.1996.11747839","volume":"16","author":"C Luxemburger","year":"1996","unstructured":"Luxemburger C, Price RN, Nosten F, ter Kuile FO, Chongsuphajaisiddhi T, White NJ: Mefloquine in infants and young children. Ann Trop Paediatr. 1996, 16: 281-6.","journal-title":"Ann Trop Paediatr"},{"key":"23_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1708-8305.1996.tb00750.x","volume":"4","author":"ML Mittelholzer","year":"1996","unstructured":"Mittelholzer ML, Wall M, Steffen R, St\u00fcrchler D: Malaria prophylaxis in different age groups. J Travel Med. 1996, 4: 219-23.","journal-title":"J Travel Med"},{"key":"23_CR23","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/infdis\/166.6.1393","volume":"166","author":"FO ter Kuile","year":"1992","unstructured":"ter Kuile FO, Nosten F, Thieren M, Luxemburger C, Edstein MD, Chongsuphajaisiddhi T, Phaipun L, Webster HK, White NJ: High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. J Infect Dis. 1992, 166: 1393-400.","journal-title":"J Infect Dis"},{"key":"23_CR24","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2165\/00002018-199512060-00003","volume":"12","author":"P Phillips-Howard","year":"1995","unstructured":"Phillips-Howard P, ter Kuile FO: CNS adverse events associated with antimalarial agents. Drug Saf. 1995, 12: 370-83.","journal-title":"Drug Saf"},{"key":"23_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4269\/ajtmh.1998.58.17","volume":"58","author":"B Vanhauwere","year":"1998","unstructured":"Vanhauwere B, Maradit H, Kerr L: Post-marketing surveillance of prophylactic mefloquine (Lariam\u00ae) use in pregnancy. Am J Trop Med Hyg. 1998, 58: 17-21.","journal-title":"Am J Trop Med Hyg"},{"key":"23_CR26","doi-asserted-by":"crossref","unstructured":"Croft AMJ, Garner P: Mefloquine for preventing malaria in non-immune adult travellers (Cochrane Review). In: Cochrane Library. 2001, Oxford: Update Software, 1","DOI":"10.1002\/14651858.CD000138"},{"key":"23_CR27","first-page":"683","volume-title":"In: Haslett C, Chilvers ER, Hunter JAA, Boon NA, editors. Davidson 's Principles and Practice of Medicine","author":"NDC Finlayson","year":"1999","unstructured":"Finlayson NDC, Hayes PC, Simpson KJ: Diseases of the liver and biliary system. In: Haslett C, Chilvers ER, Hunter JAA, Boon NA, editors. Davidson 's Principles and Practice of Medicine. 1999, London: Churchill Livingstone, 683-736. 18","edition":"18"},{"key":"23_CR28","first-page":"543","volume-title":"In: Davidson's Principles and Practice of Medicine","author":"CRW Edwards","year":"1999","unstructured":"Edwards CRW, Toft AD, Walker BR: Endocrine disease. In: Davidson's Principles and Practice of Medicine. Edited by: Haslett C, Chilvers ER, Hunter JAA, Boon NA. 1999, London: Churchill Livingstone, 543-98. 18","edition":"18"},{"key":"23_CR29","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/0006-2952(92)90638-Y","volume":"43","author":"KN Bangchang","year":"1992","unstructured":"Bangchang KN, Karbwang J, Back DJ: Mefloquine metabolism by human liver microsomes: effect of other antimalarial drugs. Biochem Pharmacol,. 1992, 43: 1957-61. 10.1016\/0006-2952(92)90638-Y.","journal-title":"Biochem Pharmacol,"},{"key":"23_CR30","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1592\/phco.20.19.1517.34856","volume":"20","author":"I Gotsman","year":"2000","unstructured":"Gotsman I, Azaz-Livshits T, Fridlender Z, Muszkat M, Ben-Chetrit E: Mefloquine-induced acute hepatitis. Pharmacotherapy. 2000, 20: 1517-9. 10.1592\/phco.20.19.1517.34856.","journal-title":"Pharmacotherapy"},{"key":"23_CR31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4269\/ajtmh.1996.55.230","volume":"55","author":"CAJJ Jaspers","year":"1996","unstructured":"Jaspers CAJJ, Hopperus Buma APCC, van Thiel PPAM, van Hulst RA, Kager PA: Tolerance of mefloquine chemoprophylaxis in Dutch military personnel. Am J Trop Med Hyg. 1996, 55: 230-4.","journal-title":"Am J Trop Med Hyg"},{"key":"23_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2149\/tmh1973.22.185","volume":"22","author":"S Takeshima","year":"1994","unstructured":"Takeshima S: Side effects with mefloquin for long-term malaria prophylaxis. Jpn J Trop Med Hyg. 1994, 22: 193-8.","journal-title":"Jpn J Trop Med Hyg"},{"key":"23_CR33","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/0035-9203(89)90253-8","volume":"83","author":"EC Reisinger","year":"1989","unstructured":"Reisinger EC, Horstmann RD, Dietrich M: Tolerance of mefloquine alone and in combination with sulfadoxine-pyrimethamine in the prophylaxis of malaria. Trans R Soc Trop Med Hyg. 1989, 83: 474-7. 10.1016\/0035-9203(89)90253-8.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"23_CR34","first-page":"2124","volume-title":"In: Oxford Textbook of Medicine","author":"J Neuberger","year":"1996","unstructured":"Neuberger J: Drugs and liver damage. In: Oxford Textbook of Medicine. Edited by: Weatherall DJ, Ledingham JGG, Warrell DA. 1996, Oxford: Oxford University Press, 2124-30. 3","edition":"3"},{"key":"23_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0140-6736(05)74932-1","volume":"353","author":"A Grieco","year":"1999","unstructured":"Grieco A, Vecchio FM, Natale L, Gasbarrini G: Acute fatty liver after malaria prophylaxis with mefloquine. Lancet. 1999, 353: 295-6.","journal-title":"Lancet"},{"key":"23_CR36","first-page":"515","volume":"152","author":"RC Wittes","year":"1995","unstructured":"Wittes RC, Saginur R: Adverse reaction to mefloquine associated with ethanol ingestion. Can Med Assoc J. 1995, 152: 515-7.","journal-title":"Can Med Assoc J"},{"key":"23_CR37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s002280050144","volume":"50","author":"EFPM Vuurman","year":"1996","unstructured":"Vuurman EFPM, Muntjewerff ND, Uiterwijk MMC, van Veggel LMA, Crevoisier C, Haglund L, Kinzig M, O'Hanlon JF: Effects of mefloquine alone and with alcohol on psychomotor and driving performance. Eur J Clin Pharmacol. 1996, 50: 475-82. 10.1007\/s002280050144.","journal-title":"Eur J Clin Pharmacol"},{"key":"23_CR38","first-page":"404","volume":"67","author":"K Meszaros","year":"1996","unstructured":"Meszaros K, Kasper S: Psychopathologische Ph\u00e4nomene im Langzeitverlauf einer akuten Psychose nach Mefloquinprophylaxe (Lariam\u00ae). Nervenarzt. 1996, 67: 404-6.","journal-title":"Nervenarzt"},{"key":"23_CR39","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/0140-6736(93)90392-T","volume":"341","author":"GM Gullahorn","year":"1993","unstructured":"Gullahorn GM, Bohman HR, Wallace MR: Anaesthesia emergence delirium after mefloquine prophylaxis. Lancet. 1993, 341: 632-10.1016\/0140-6736(93)90392-T.","journal-title":"Lancet"},{"key":"23_CR40","first-page":"4003","volume":"110","author":"A Castot","year":"1988","unstructured":"Castot A, Gamier R: R\u00e9flexion sur les effets secondaires de la m\u00e9floquine. Concours Med. 1988, 110: 4003-","journal-title":"Concours Med"},{"key":"23_CR41","first-page":"516","volume":"100","author":"JI Conget","year":"1993","unstructured":"Conget JI, Navarro M, Navarro P, Corach\u00e1n M: Alteraci\u00f3n del perfil hormonal tiroideo tras la administraci\u00f3n profil\u00e1ctica de mefloquina. Med Cl\u00edn (Barcelona). 1993, 100: 516-","journal-title":"Med Cl\u00edn (Barcelona)"},{"key":"23_CR42","volume-title":"Proceedings of the Fifth International Conference on Travel Medicine; 1997 Mar 24\u201327; Geneva, Switzerland. Geneva: International Society of Travel Medicine,","author":"WM Bauer","year":"1997","unstructured":"Bauer WM, Craig CP: Acute psychotic reactions in an aid worker following separate administrations of mefloquine and iodoquinol. Proceedings of the Fifth International Conference on Travel Medicine; 1997 Mar 24\u201327; Geneva, Switzerland. Geneva: International Society of Travel Medicine,. 1997"},{"key":"23_CR43","first-page":"361","volume":"54","author":"X Nicolas","year":"1994","unstructured":"Nicolas X, Touze JE: La toxicit\u00e9 cardiaque des antipaludiques. Med Trop. 1994, 54: 361-5.","journal-title":"Med Trop"},{"key":"23_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1128\/AAC.12.1.51","volume":"12","author":"LH Schmidt","year":"1977","unstructured":"Schmidt LH, Alexander S, Allen L, Rasco J: Comparison of the curative antimalarial activities and toxicities of primaquine and its d and l isomers. Antimicrob Agents Chemother. 1977, 12: 51-60.","journal-title":"Antimicrob Agents Chemother"},{"key":"23_CR45","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/bmj.292.6522.721","volume":"292","author":"K Neftel","year":"1986","unstructured":"Neftel K, Woodtly W, Schmid M, Frick PG, Fehr J: Amodiaquine induced agranulocytosis and liver damage. BMJ. 1986, 292: 721-3.","journal-title":"BMJ"},{"key":"23_CR46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.7326\/0003-4819-104-6-801","volume":"104","author":"D Larrey","year":"1986","unstructured":"Larrey D, Castot A, Pessayre D, Merigot P, Machayekhy JP, Feldmann G, Lenoir A, Rueff B, Benhamou JP: Amodiaquine-induced hepatitis. A report of seven cases. Ann Intern Med. 1986, 104: 801-3.","journal-title":"Ann Intern Med"},{"key":"23_CR47","first-page":"966","volume":"116","author":"W Woodtli","year":"1986","unstructured":"Woodtli W, Vonmoos P, Siegrist P, Zollikofer H: Amodiaquin-induzierte Hepatitis mit Leukopenie. Schweiz Med Wochenschr. 1986, 116: 966-8.","journal-title":"Schweiz Med Wochenschr"},{"key":"23_CR48","first-page":"266","volume":"80","author":"G Charmot","year":"1987","unstructured":"Charmot G, Goujon C: H\u00e9patites mineures pouvant \u00eatres dues \u00e0 l'amodiaquine. Bull Soc Pathol Exot. 1987, 80: 266-70.","journal-title":"Bull Soc Pathol Exot"},{"key":"23_CR49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0168-8278(88)80469-0","volume":"6","author":"J Bernuau","year":"1988","unstructured":"Bernuau J, Larrey D, Campillo B, Degott C, Verdier F, Rueff B, Pessayred D, Benhamou JP: Amodiaquine-induced fulminant hepatitis. J Hepatol. 1988, 6: 109-12.","journal-title":"J Hepatol"},{"key":"23_CR50","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/00004836-198910000-00034","volume":"11","author":"JM Raymond","year":"1989","unstructured":"Raymond JM, Dumas F, Baldit C, Couzigou P, Beraud C, Amouretti M: Fatal acute hepatitis due to amodiaquine. J Clin Gastroenterol. 1989, 11: 602-3.","journal-title":"J Clin Gastroenterol"},{"key":"23_CR51","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1136\/bmj.314.7094.1593","volume":"314","author":"Y Munera","year":"1997","unstructured":"Munera Y, Hughes FC, Le Jeunne C, Pays JF: Interaction of thyroxine sodium with antimalarial drugs. BMJ. 1997, 314: 1593-","journal-title":"BMJ"},{"key":"23_CR52","first-page":"1603","volume-title":"In: Oxford Textbook of Medicine","author":"AM McGregor","year":"1996","unstructured":"McGregor AM: The thyroid gland and disorders of thyroid function. In: Oxford Textbook of Medicine. Edited by: Weatherall DJ, Ledingham JGG, Warrell DA. 1996, Oxford: Oxford University Press, 1603-18. 3","edition":"3"},{"key":"23_CR53","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-3-642-60709-7_13","volume-title":"In: Pharmacotherapeutics of the Thyroid Gland","author":"JW Barlow","year":"1997","unstructured":"Barlow JW, Crowe TC, Topliss DJ: Thyroid hormone antagonism. In: Pharmacotherapeutics of the Thyroid Gland. Edited by: Weetman AP, Grossman A. 1997, London: Springer, 319-42."},{"key":"23_CR54","first-page":"50","volume":"60","author":"EA Stroev","year":"1997","unstructured":"Stroev EA, Kochukov MY, Nikolaev VV: The lysosomal proteolytic system and functional activity of the rat thyroid in chloroquine administration. Eksp Klin Farmakol. 1997, 60: 50-2.","journal-title":"Eksp Klin Farmakol"},{"key":"23_CR55","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1046\/j.1365-2230.1999.00471.x","volume":"24","author":"HR Smith","year":"1999","unstructured":"Smith HR, Croft AM, Black MM: Dermatological adverse effects with the antimalarial drug mefloquine: a review of 74 published case reports. Clin Exp Derm. 1999, 24: 249-54. 10.1046\/j.1365-2230.1999.00471.x.","journal-title":"Clin Exp Derm"},{"key":"23_CR56","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/(SICI)1097-0258(19980815\/30)17:15\/16<1839::AID-SIM986>3.0.CO;2-G","volume":"17","author":"D Ashby","year":"1998","unstructured":"Ashby D, Smyth RL, Brown PJ: Statistical issues in pharmacoepidemiological case-control studies. Statist Med. 1998, 17: 1839-50. 10.1002\/(SICI)1097-0258(19980815\/30)17:15\/16<1839::AID-SIM986>3.3.CO;2-7.","journal-title":"Statist Med"},{"key":"23_CR57","first-page":"257","volume":"44","author":"E Boudreau","year":"1993","unstructured":"Boudreau E, Schuster B, Sanchez J, Novakowski W, Johnson R, Redmond D, Hanson R, Dausel L: Tolerability of prophylactic Lariam\u00ae regimens. Trop Med Parasitol. 1993, 44: 257-65.","journal-title":"Trop Med Parasitol"},{"key":"23_CR58","first-page":"2723","volume":"159","author":"E Petersen","year":"1997","unstructured":"Petersen E: Malariaprofylakse. Virkninger og bivirkninger af farmaka der bruges til forebyggelse af malaria. Ugeskr L\u00e6ger. 1997, 159: 2723-30.","journal-title":"Ugeskr L\u00e6ger"},{"key":"23_CR59","first-page":"2410","volume":"160","author":"VV Olsen","year":"1998","unstructured":"Olsen VV: Principielle overvejelser vedr\u00f8rende malariaprofylakse. Ugeskr L\u00e6ger. 1998, 160: 2410-1.","journal-title":"Ugeskr L\u00e6ger"},{"key":"23_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(85)90078-9","volume":"ii","author":"E Ragan","year":"1985","unstructured":"Ragan E, Wilson R, Li F, Spasoff R, Bigelow G, Spinner N: Psychotic symptoms in volunteers serving overseas. Lancet. 1985, ii: 37-10.1016\/S0140-6736(85)90078-9.","journal-title":"Lancet"},{"key":"23_CR61","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2310\/7060.2000.00002","volume":"7","author":"I Potasman","year":"2000","unstructured":"Potasman I, Berry A, Seligmann H: Neuropsychiatric problems in 2,500 long-term young travellers to the tropics. J Travel Med. 2000, 7: 5-9.","journal-title":"J Travel Med"},{"key":"23_CR62","first-page":"300","volume":"63","author":"H Folkerts","year":"1996","unstructured":"Folkerts H, Kuhs H: Psychotische Episode infolge Malariaprophylaxe mit Mefloquin: eine kasuistische Mitteilung. Nervenarzt. 1996, 63: 300-2.","journal-title":"Nervenarzt"},{"key":"23_CR63","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1055\/s-2007-1017970","volume":"21","author":"D Grupp","year":"1994","unstructured":"Grupp D, Rauber A, Fr\u00f6scher W: Neuropsychiatrische st\u00f6rungen nach malariaprophylaxe mit mefloquin. Akt Neurol. 1994, 21: 134-6.","journal-title":"Akt Neurol"},{"key":"23_CR64","first-page":"6044","volume":"156","author":"AM R\u00f8nn","year":"1994","unstructured":"R\u00f8nn AM, Bygbjerg IC: Akut hjernesyndrom efter meflokinbehandling. Ugeskr L\u00e6ger. 1994, 156: 6044-5.","journal-title":"Ugeskr L\u00e6ger"},{"key":"23_CR65","first-page":"33","volume":"22","author":"M Hollweg","year":"1995","unstructured":"Hollweg M: Mefloquininduzierte Psychosen \u2013 Probleme der Kausalzuordnung anhand zweier kasuistischer Berichte. Psychiatr Prax. 1995, 22: 33-6.","journal-title":"Psychiatr Prax"},{"key":"23_CR66","first-page":"2477","volume":"142","author":"M Heeringa","year":"1998","unstructured":"Heeringa M, Kuster JAM, Meyboom RHB, Bouvy M: Convulsies tijdens profylactisch gebruik van mefloquine. Ned Tijdschr Geneeskd. 1998, 142: 2477-80.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"23_CR67","first-page":"241","volume":"160","author":"JB Jensen","year":"1998","unstructured":"Jensen JB, Meflochin : De neuropsykiatriske bivirkninger er ofte alvorlige og kan persistere l\u00e6nge efter oph\u00f8r med medicinen. Ugeskr L\u00e6ger. 1998, 160: 241-","journal-title":"Ugeskr L\u00e6ger"},{"key":"23_CR68","first-page":"1422","volume":"161","author":"IC Bygberg","year":"1999","unstructured":"Bygberg IC, R\u00f8nn AM: Langvarige neuropsykiatriske bivirkninger efter meflochinprofylakse. Ugeskr L\u00e6ger. 1999, 161: 1422-3.","journal-title":"Ugeskr L\u00e6ger"},{"key":"23_CR69","first-page":"379","volume":"150","author":"M Fusetti","year":"1999","unstructured":"Fusetti M, Eibenstein A, Corridore V, Hueck S, Chiti-Batelli S: Meflochina ed ototossicit\u00e0: descrizione di tre casi. Clin Ter. 1999, 150: 379-82.","journal-title":"Clin Ter"},{"key":"23_CR70","first-page":"1119","volume":"27","author":"JT Lysack","year":"1998","unstructured":"Lysack JT, Lysack CL, Kvern BL: A severe adverse reaction to mefloquine and chloroquine prophylaxis. Aust Fam Physician. 1998, 27: 1119-20.","journal-title":"Aust Fam Physician"},{"key":"23_CR71","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1046\/j.1365-3156.1998.00287.x","volume":"3","author":"J Van den Ende","year":"1998","unstructured":"Van den Ende J, Coppens G, Verstraeten T, van Haegenborgh T, Depraetere K, van Gompel A, van den Enden E, Clerinx J, Colebunders R, Peetermans WE, et al: Recurrence of blackwater fever: triggering of relapses by different antimalarials. Trop Med Int Health. 1998, 3: 632-9. 10.1046\/j.1365-3156.1998.00287.x.","journal-title":"Trop Med Int Health"},{"key":"23_CR72","first-page":"170","volume":"89","author":"DN Durrheim","year":"1999","unstructured":"Durrheim DN, Gammon S, Waner S, Braack LEO: Antimalarial prophylaxis \u2013 use and adverse events in visitors to the Kruger National Park. S Afr Med J. 1999, 89: 170-5.","journal-title":"S Afr Med J"},{"key":"23_CR73","first-page":"47","volume":"13","author":"SS Mangalvedhekar","year":"2000","unstructured":"Mangalvedhekar SS, Gogtay NJ, Wagh VR, et al: Convulsions in non-epileptics due to mefloquine-fluoroquinolone co-administration. Natl Med J India. 2000, 13: 47-","journal-title":"Natl Med J India"},{"key":"23_CR74","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0140-6736(00)02505-8","volume":"356","author":"F Nosten","year":"2000","unstructured":"Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ: Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet. 2000, 356: 297-302. 10.1016\/S0140-6736(00)02505-8.","journal-title":"Lancet"},{"key":"23_CR75","first-page":"721","volume":"308","author":"JC Merritt","year":"1994","unstructured":"Merritt JC: Mefloquine not first choice for aircrew. BMJ. 1994, 308: 721-2.","journal-title":"BMJ"},{"key":"23_CR76","first-page":"103","volume":"60","author":"P Heno","year":"2000","unstructured":"Heno P: \u00c0 propos de plong\u00e9es et tropiques. Med Trop. 2000, 60: 103-","journal-title":"Med Trop"},{"key":"23_CR77","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1136\/bmj.310.6995.1673a","volume":"310","author":"IC Perry","year":"1995","unstructured":"Perry IC: Malaria prophylaxis. BMJ. 1995, 310: 1673-","journal-title":"BMJ"},{"key":"23_CR78","first-page":"549","volume":"199","author":"J Botella de Maglia","year":"1998","unstructured":"Botella de Maglia J, Casanovas AE: Acerca de la profllaxis del paludismo. Rev Clin Esp. 1998, 199: 549-50.","journal-title":"Rev Clin Esp"},{"key":"23_CR79","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/0140-6736(93)93058-9","volume":"341","author":"HO Lobel","year":"1993","unstructured":"Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC: Long-term prophylaxis with weekly mefloquine. Lancet. 1993, 341: 848-51. 10.1016\/0140-6736(93)93058-9.","journal-title":"Lancet"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-2-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-2-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-2-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-2-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:34:46Z","timestamp":1726245286000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-2-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,25]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,12]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-2-6","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3,25]]},"assertion":[{"value":"17 December 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}